Table 1.

Relative Fold-Change in BDG From Baseline Between Treatment Arms

Treatment Comparison		Change From Baseline at
		Week 4	Week 24	Week 96
ATV/r vs DRV/r	Mean (97.5% CI)	1.39 (0.79 to 2.42)	1.03 (0.74 to 1.44)	1.09 (0.79 to 1.50)
	P	.38	.71	.27
ATV/r vs RAL	Mean (97.5% CI)	1.17 (0.68 to 1.99)	1.03 (0.71 to 1.49)	1.09 (0.77 to 1.56)
	P	.65	.50	.24
RAL vs DRV/r	Mean (97.5% CI)	0.84 (0.48 to 1.48)	0.99 (0.70 to 1.40)	1.01 (0.72 to 1.41)
	P	.68	.69	.84

Pairwise treatment group comparisons of relative fold-change in BDG from baseline and respective study visit.

Abbreviations: ATV/r, atazanavir-ritonavir; BDG, β-D-glucan; CI, confidence interval; DRV/r, darunavir-ritonavir; RAL, raltegravir.